Acadia Healthcare (NASDAQ:ACHC) Trading Down 5.8% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares were down 5.8% on Tuesday . The stock traded as low as $14.41 and last traded at $14.3530. Approximately 187,924 shares changed hands during trading, a decline of 95% from the average daily volume of 3,577,125 shares. The stock had previously closed at $15.23.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. UBS Group dropped their price objective on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Leerink Partners reiterated a “market perform” rating and issued a $14.00 price target (down previously from $25.00) on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Bank of America cut shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Guggenheim reduced their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Finally, Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating for the company in a research note on Wednesday, January 14th. Six investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $18.62.

Acadia Healthcare Stock Down 2.9%

The stock has a market cap of $1.20 billion, a PE ratio of 11.15, a PEG ratio of 3.82 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The company has a 50 day moving average price of $14.38 and a two-hundred day moving average price of $19.35.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The company had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same quarter last year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently bought and sold shares of ACHC. Allworth Financial LP raised its stake in Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares in the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after acquiring an additional 1,822 shares during the last quarter. CWM LLC grew its position in Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after acquiring an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC bought a new stake in Acadia Healthcare during the third quarter worth approximately $71,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.